EsoGuard esophageal precancer testing volume rose 25 percent to 3,034 tests in the first quarter compared to 2,420 tests in Q1 2024.

Upfront will use the proceeds to accelerate the commercialization of its lateral flow test, called LVOne, for triaging stroke patients in the UK, Europe, and US.

Last week, readers were most interested in a story about Castle Biosciences' buy of Previse and its plans to expand its gastrointestinal diagnostic test offerings.

The home-collected vaginal samples can be shipped to CLIA-certified labs for testing on the Roche Cobas system.

NEW YORK – Although it had multiple products with regulatory clearance and technology that had been validated by outside users, Accelerate Diagnostics' inability to attract buyers for its instruments ...

NEW YORK – For decades now, consolidation has been one of the major trends in the clinical laboratory market as major players like Quest Diagnostics, Laboratory Corporation of America, and Sonic ...

Note: This story has been updated with comments from a conference call to discuss the firm's financial results. NEW YORK – Siemens Healthineers said Wednesday that it expects tariffs implemented by ...

The agreement enables rapid diagnostic test manufacturing in the Africa region and will initially focus on HIV testing.

NEW YORK – Kiffik Biomedical and Rubix LS are working together to combine an interstitial fluid collection device and aptamer biosensing for rapid, at-home, cancer detection at the point of care.

NEW YORK – Japanese digital pathology startup Medmain said on Thursday that it has raised $3.3 million through a third-party allotment of shares with investors. The funding round was led by One ...